What it is best to know:

– Tandem Diabetes Care and Abbott have joined forces to convey the primary automated insulin supply system (AID) to the U.S. suitable with Abbott's newest FreeStyle Libre 2 Plus sensor.

– The combination brings the advantages of superior closed-loop know-how to tens of millions of Individuals residing with diabetes, serving to them obtain higher blood sugar management and extra simply handle their situation.

Seamless integration for exact management:

The t:slim X2 insulin pump, outfitted with Management-IQ know-how, now connects wirelessly to the FreeStyle Libre 2 Plus sensor. This steady glucose monitoring (CGM) system delivers minute-by-minute glucose knowledge on to the pump and its companion app. Management-IQ then makes use of this real-time info to foretell glucose ranges half-hour prematurely and routinely modify insulin supply each 5 minutes, stopping each hyperglycemia and hypoglycemia.

Key advantages for customers

– Lowered burdens: The combination simplifies diabetes administration by eliminating finger sticks and the necessity for separate CGM gadgets.

– Improved blood sugar management: Management-IQ's proactive insulin changes assist stop excessive and low blood sugar ranges, main to higher general glucose administration.

– Customized expertise: The system is very customizable, permitting customers to tailor the settings to their particular person wants and preferences.

Abbott's innovation

The FreeStyle Libre 2 Plus sensor has a number of options that make it preferrred for AID compatibility:

– 15 days gestation interval: This prolonged put on interval reduces the necessity for frequent sensor adjustments, offering comfort and price financial savings.

– Confirmed accuracy: The sensor supplies extremely correct glucose readings, guaranteeing dependable knowledge for Management-IQ's algorithms.

– Discreet and comfy: The sensor is small and light-weight, making it snug to put on for prolonged intervals.

“Tandem's management in AID innovation is underscored with this milestone launch of the primary insulin pump suitable with Abbott's CGM know-how within the U.S.,” mentioned John Sheridan, president and CEO of Tandem Diabetes Care . “This represents one other step ahead in our dedication to offering customizable options to assist scale back burdens and create new alternatives for folks with diabetes.”